CNS Demyelinating Disease Evaluation

Synonyms

• CDS1
• CNS DEMYELINATING DISEASE EVAL
• LAB4235

Cerner Name

CNS Demyelinating Disease Evaluation

Clinical Info

Diagnosis of inflammatory demyelinating diseases (IDDs) with similar phenotype to neuromyelitis optica spectrum disorder (NMOSD),
including optic neuritis (single or bilateral) and transverse myelitis
Diagnosis of autoimmune myelin oligodendrocyte glycoprotein-opathy
Diagnosis of neuromyelitis optica
Distinguishing NMOSD, acute disseminated encephalomyelitis (ADEM), optic neuritis, and transverse myelitis 
from multiple sclerosis early in the course of disease
Diagnosis of ADEM
Prediction of a relapsing disease course

Specimen Sources

Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous

Specimen Types

Blood

Specimen Volume

Specimen Volume: 3 mL (2 mL Min Volume)

Container

Collection Container/Tube:
Preferred: Red top
Acceptable: Serum gel

Collection Instructions

Collection Container/Tube:
Preferred: Red top
Acceptable: Serum gel
Submission Container/Tube: Plastic vial
Specimen Volume: 3 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.

Transport Instructions

Refrigerated

Specimen Stability

Refrigerated (preferred) 28 days
Ambient 72 hours
Frozen 28 days

Methodology

Flow Cytometry

Days Performed

Day(s) Performed 
Monday, Tuesday, Thursday
TAT: 8-11 Days

Performing Laboratories

• Mayo Medical Laboratories

CPT

86053,86363

PDM

255525

Results

Result Interpretation

Forms